18:21 Analyse Alstom: talks confirmed with Siemens.
17:42 Analyse Vivendi: abstains from voting at Ubisoft's AGM.
17:11 Analyse Compass: Oddo confirms rating after CEO leaves group.
15:50 Analyse Siemens: in talks with Bombardier and Alstom.
15:47 Analyse Chevron: agreement with Total in the Gulf of Mexico.
15:41 Analyse Icade: trial of an autonomous shuttle service.
15:29 Analyse Renault: Captur starts up in the Indian Market.
14:53 Analyse Air France-KLM: Goldman Sachs reduces stake.
14:42 Analyse Exxonmobil: Texas refineries to reopen.
14:35 Analyse ABB: talks with GE close to completion.
14:17 Analyse Rio Tinto: decides on new share repurchases.
13:53 Analyse Texas Instruments: increase in dividend and share buybacks.
12:39 Analyse HP Enterprise: could cut workforce by 10%.
12:31 Analyse Valeo: receives award for its transparency.
12:19 Analyse Prosiebensat: Liberum cuts target, preferring RTL.
12:13 Analyse Marie Brizard: Bryan Garnier cuts target price.
12:02 Analyse L'Oréal: UBS no longer believes in Nestlé speculation.
11:49 Analyse Lufthansa: Oddo raises target price.
11:38 Analyse Tikehau Capital: returns to profit in H1.
10:47 Analyse Alstom: in talks with Siemens, like Bombardier.
10:30 Analyse Roche: GCA drug approval in Europe.
10:19 Analyse Statoil: already reaches 2020 target in terms of CO2.
10:07 Analyse CGG: PPlocal opposes restructuring plan.
09:45 Analyse Adecco: investor day on outlook to 2020.
09:39 Analyse Total: agreement with Chevron in the Gulf of Mexico.
09:25 Analyse Carrefour: nomination of a group executive committee.
09:03 Analyse Safran: receives 'best performer award' from Airbus.
09:01 Analyse L'Oréal: Liliane Bettencourt dies.
16:50 Analyse Inditex: share down after publication of Q2 results.
15:13 Analyse Mersen: Norwegian Sovereign fund reduces its exposure.
14:37 Analyse Alphabet: agreement between Google and HTC.
14:18 Analyse BASF: invests in specialty zeolities.
14:06 Analyse Lufthansa: soon to extend its fleet.
12:38 Analyse Siemens: director of cyber-security at SGRE.
12:34 Analyse Total: UBS a buyer ahead of investor day.
12:26 Analyse SFR Group: buyout offer starts.
12:15 Analyse Inditex: Invest Securities adjusts target price.
11:59 Analyse Plastic Omnium: Aurel BGC welcomes planned disposal.
11:52 Analyse Hugo Boss: Commerzbank raises target price.
11:37 Analyse BBVA: could sell real estate assets to Cerberus.
11:28 Analyse Thyssenkrupp: SG welcomes TATA Steel deal.
11:09 Analyse CRH: Bryan Garnier still a buyer.
10:52 Analyse CRH: stock up with acquisition in the US.
10:47 Analyse Vallourec: wins contract with Shell joint venture in Egypt.
10:43 Analyse EDF: diplomat from Quai d'Orsay joins board.
10:31 Analyse Richemont: takes on a CTO and head of HR.
10:18 Analyse Total: decides to distribute interim dividend.
09:55 Analyse Société Générale: resignation of Boursorama's CEO.
09:43 Analyse Europcar: acquisition of Buchbinder finalised.
09:38 Analyse Nicox: exclusive license with Eyevance for zerviate.
09:37 Analyse Plastic Omnium: plans to sell environment division.
08:59 Analyse Airbus: organises its best in class awards.
08:55 Analyse Crédit Agricole: completes a disposal.
16:52 Analyse Eurosic: simplified tender offer approved by AMF.
16:12 Analyse Diageo: interim profit warning.
16:04 Analyse A.P. Moeller-Maersk: disposal of tanker business.
15:52 Analyse Inditex: H1 earnings slightly under expectations.
15:43 Analyse Bureau Veritas: Oddo is a buyer.
15:28 Analyse Sanofi: successful Apollo study on Patisiran.
15:13 Analyse General Mills: disappointing start to new fiscal year.
15:03 Analyse ASML: BarCap raises target price.
14:54 Analyse Havas: tender offer starts on 21 September.
14:22 Analyse Fedex: far short of expectations in Q1.
13:59 Analyse Kingfisher: soaring after interim results.
12:17 Analyse Dassault Aviation: Oddo remains neutral after road show.
12:08 Analyse Alstom: signs contract for Chengdu Metro.
12:02 Analyse Thyssenkrupp: MoU with Tata Steel.
11:50 Analyse Ipsen: European approval for Xermelo.
11:37 Analyse Engie: "Green Bond" issue of 1.25 billion euros.
11:19 Analyse Soitec: soars 8% on LT agreement with Globalfoundries.
10:51 Analyse Suez: too expensive for Credit Suisse, it downgrades stock.
10:24 Analyse Engie: windfarm platform developed in India with Abraaj.
10:13 Analyse Capgemini: acquisition of Lyons Consulting Group.
10:06 Analyse Ipsen: Société Générale upgrades to buy.
09:50 Analyse Telecom Italia: will dispute Consob's decision.
09:41 Analyse Airbus: inaugurates its A330 C&DC in Tianjin.
09:27 Analyse Capgemini: launches fourth ESOP.
09:15 Analyse Teleperformance: integrates two new indices.
09:12 Analyse Europcar: completes acquisition of Lor'rent.
09:11 Analyse Nexity: sale of complex before completion in Gironde.
17:20 Analyse Nokia: transformation project in France.
16:47 Analyse SFR Group: go-ahead from AMF for planned squeeze-out.
16:16 Analyse Société Générale: opens a representative office in Kenya.
16:01 Analyse Thales: creation of an artificial nano-neuron.
15:46 Analyse Havas: go-ahead from AMF for Opas project.
15:32 Analyse Autozone: slight increase in Q4 earnings.
15:25 Analyse Nokia: will modernise Ukkoverkot network in Finland.
15:18 Analyse Mattel: should benefit from setbacks at Toys 'r' Us.
15:12 Analyse Nike: Susquehanna downgrades its rating.
15:04 Analyse Swiss Life AM: robust level of net new money in H1.
14:46 Analyse Allianz: change in top management at German division?
12:52 Analyse Ryanair: a buy opportunity, according to SG.
12:30 Analyse Moncler: stock down after a broker's downgrade.
12:19 Analyse Telecom Italia: denies spin-off or sale of network.
12:13 Analyse Inditex: Morgan Stanley downgrades its rating.
11:58 Analyse Solvay: Oddo confirms rating.
11:32 Analyse Kering: ranked most sustainable company by DJSI.
11:21 Analyse Total: Oddo a buyer ahead of investor day.
10:53 Analyse GSK: approval of Trelegy Ellipta in the US.
10:42 Analyse BASF: towards purchase of Solvay's polyamides business.
10:36 Analyse Heineken: Mexican Femsa sells 5% of its capital.
10:31 Analyse Solvay: agreement for sale of polyamides business.
10:28 Analyse Dassault Systèmes: Chevron Products selects 3DExperience.
10:25 Analyse Total: agrees to invest in EREN RE.
10:20 Analyse Akzo Nobel: has now found next CFO.
10:18 Analyse JCDecaux: wins contracts in Lyon.
10:04 Analyse AB Inbev: Bryan Garnier maintains 'buy' rating.
09:23 Analyse Wendel: will sell its stake in Exceet group.
16:48 Analyse Mediaset España: Credit Suisse downgrades outperform rating.
16:24 Analyse Amazon: to open fourth center in Oregan, in Portland.
16:11 Analyse Caterpillar: UBS upgrades to buy.
15:54 Analyse Amazon: to open fourth center in Ohio, in Monroe.
15:42 Analyse Mediaset España: weighed on by an analyst's downgrade.
15:34 Analyse Teva: sale of several assets in women's health.
14:45 Analyse Northrop Grumman: acquisition of Orbital ATK.
14:42 Analyse Linde: remains in DJSI indices.
14:35 Analyse Airbus Group: denies accusations from Austria.
12:29 Analyse Renault: two acquisitions of RCI Bank and Services.
12:13 Analyse Siemens: Siemens Gamesa wins big contract in China.
12:03 Analyse Alstom: showcases Aptis, its 100%-electric vehicle.
11:50 Analyse Renault: Oddo confirms rating after group's conference.
11:42 Analyse Nokia: arbitration ruling on licenses.
11:30 Analyse ArcelorMittal: eyes on Bhushan Steel.
11:19 Analyse Elior: contract with LVMH.
10:54 Analyse SES: wins contract in Turkey.
10:34 Analyse Ryanair: Liberum still a buyer, despite cancellations.
10:27 Analyse Saint-Gobain: launches Eclaz range.
10:12 Analyse Havas: acquisition of the agency, The 88.
09:47 Analyse Veolia: contract for Seine amont treatment plant.
09:38 Analyse Sodexo: concludes sale of Vivabox.
09:31 Analyse Latécoère: returns to profit in H1.
09:24 Analyse Ipsen: FDA approves indication for Somatuline.
09:14 Analyse Sanofi: positive results from study on Dupixent.
09:13 Analyse Hermes: Oddo slightly revises EPS and target price.
16:28 Analyse FedEx: shares down as UBS downgrades on TNT issues.
16:16 Analyse Bayer: another positive CHMP opinion for Xarelto.
16:13 Analyse GSK: EU agency recommends new form for lupus drug.
15:59 Analyse Orange: proposes new generation of Apple products.
15:42 Analyse Eramet: inaugurates titanium plant.
15:33 Analyse Johnson & Johnson: positive opinion for guselkumab in Europe
15:21 Analyse Renault: partnership confirmed with MClaren.
15:13 Analyse Carnival: Credit Suisse downgrades stock.
14:31 Analyse Ford: European sales down 2.4% in August.
14:25 Analyse Oracle: mixed Q1 results.
12:19 Analyse Time Warner: 'Dunkirk' takings exceed 500 million dollars.
12:06 Analyse Bayer: FDA approves drug for follicular lymphoma.
12:04 Analyse Korian: cautious optimism from SG.
11:59 Analyse GlaxoSmithKline: EU committee backs new inhaler for COPD.
11:51 Analyse Uniper: SG says it's time to take profits.
11:41 Analyse Almirall: launches Skilarence in Europe for psoriasis.
11:32 Analyse Novo Nordisk: new findings in type-2 diabetes.
11:14 Analyse SES: contract in Uzbekistan for DTT.
10:57 Analyse Glencore: shares slip on UBS downgrade.
10:28 Analyse Rexel: despite Amazon, activist investor Cevian ups stake.
10:21 Analyse ABN Amro: Dutch state sells further 7% of shares.
10:12 Analyse H&M: sales rise 5% in past quarter, below forecasts.
10:05 Analyse TechnipFMC: contract with Hurricane Energy in the Shetlands.
09:48 Analyse Nestlé: buys Californian high-end coffee roaster.
09:48 Analyse Altice: Bryan Garnier cuts target price, but still a buyer.
09:19 Analyse AB Science: negative opinion from EMA on masitinib.
09:05 Analyse Pernod-Ricard: commitment to responsible marketing.
09:04 Analyse Bouygues Immobilier: H1 operating margin of 6.3%.
16:21 Analyse Statoil: extends Caspian Sea agreement until 2049.
16:07 Analyse Amazon: to open new logistics center in Michigan.
15:52 Analyse Novartis: Sandoz psoriasis generic matches Humira profile.
15:49 Analyse Facebook: introduces new crisis response center.
15:09 Analyse Orange: extends partnership with Netflix.
14:58 Analyse Next: stock soars after better guidance announced.
14:45 Analyse Adecco: Oddo BHF initiates coverage with 'buy' rating.
14:40 Analyse AstraZeneca: Aspen acquires rights to anaesthetics.
14:32 Analyse Deutsche Börse: agrees to pay fines of over 10 million euros
14:21 Analyse Elior: sets up innovative laboratory.
12:27 Analyse ING: partnership with fintech Scalable Capital in Germany.
12:17 Analyse Hydro: Sapa's executive joins management board.
12:15 Analyse Ashtead: Credit Suisse raises estimates and target price.
11:50 Analyse ING: to redeem 500 million dollars in perpetual notes.
11:45 Analyse Siemens: Chinese division to lead robotics efforts.
11:39 Analyse Hermès: beware of premium, Aurel BGC warns.
11:19 Analyse Hermès: interim profitability boosted by FX factors.
11:16 Analyse AstraZeneca: Liberum downgrades to 'hold'.
11:09 Analyse Morrisons: shares fall despite rise in half-year earnings.
10:56 Analyse Richemont: Deutsche Bank no longer a buyer.
10:38 Analyse SES: contract with TV5MONDE.
10:32 Analyse Dassault Systems: contract with Vecv in india.
10:10 Analyse Soitec: launches production line in Singapore.
10:08 Analyse Munich Re: warns on profits after hurricanes Harvey and Irma
09:59 Analyse FCA: European car sales jump 9.8% in August.
09:34 Analyse TF1: Formula 1 soon to be broadcast again.
09:27 Analyse Adecco: buys US-based life sciences specialist BioBridges.
09:21 Analyse Vivendi: disagrees with Consob on Telecom Italia.
09:15 Analyse Zodiac Aerospace: confirms FY forecasts.
09:14 Analyse Airbus: sends assistance to victims of Irma hurricane.
16:39 Analyse Airbus: finalises order with Cathay Pacific.
16:27 Analyse Generali: to sell Dutch unit for 143 million euros.
16:22 Analyse Apple: Canaccord Genuity reiterates 'buy' stance.
16:05 Analyse Apple: UBS maintains 'buy' rating after product event.
15:40 Analyse Thales: participates in a Nato exercise.
14:43 Analyse Bayer: five-year research project with Greek center.
14:40 Analyse Richemont: Aurel BGC much more optimistic on share.
14:31 Analyse Richemont: Bryan Garnier raises target after sales.
14:18 Analyse Boeing: Malaysia Airlines signs deal to buy 16 planes.
14:10 Analyse Staples: acquisition by Sycamore Partners finalised.
12:23 Analyse Sky: hurdle to approval gets higher, Credit Suisse says.
12:09 Analyse ABB: sofware deal with Geneva's public transport operator.
12:04 Analyse SAP: new features added to connected vehicle solution.
11:56 Analyse Vivendi: UBS upgrades to buy; target price of 23 euros.
11:49 Analyse Nokia: agreement with Telefonica ahead of 5G.
11:33 Analyse Logitech: shareholders approve 10% dividend increase.
11:17 Analyse Ahold Delhaize: issues Eurobond of 750 million euros.
11:15 Analyse Capgemini: SG confident; maintains target at 109 euros.
10:56 Analyse Bayer: continues to sell stake in Covestro.
10:45 Analyse easyJet: new connecting platform to book long-haul flights.
10:41 Analyse Roularta: towards takeover of the Dutch monthly Landleven.
10:32 Analyse Novartis: psoriasis drug Cosentyx shows positive results.
10:25 Analyse Eramet: Unicredit and Intesa sell stakes; discount of 10%.
10:16 Analyse Roche: new data supports Esbriet safety profile.
10:05 Analyse Richemont: sharp rebound in sales at start of fiscal year.
09:52 Analyse BMW: new record sales in August.
09:48 Analyse ADP: traffic up 3.8% in August.
09:45 Analyse Eurotunnel: passenger shuttle traffic up 3% in August.
09:43 Analyse Gemalto: IoT solution for home support.
09:14 Analyse Sanofi: new chairman soon appointed at Sanofi France.
17:05 Analyse Honeywell: collaborating with Lear on autonomous vehicles.
16:55 Analyse Eli Lilly: new analyses show diabetes drug reduces risks.
16:47 Analyse Carrefour: takes action after the Irma hurricane.
16:36 Analyse DowDuPont: several adjustments made to spin-off plans.
16:29 Analyse Engie: the State has reduced its holding to 24.1%.
16:04 Analyse Natixis: sale of Palatin I office block at La Défense.
14:53 Analyse Daimler: Oddo BHF confirms its rating.
14:48 Analyse ASML: CFO will leave company to join Bayer.
14:39 Analyse Thales: opens two centres in the UK.
12:35 Analyse Apple: expect outperformance with new iPhone, UBS says.
12:20 Analyse Vodafone: signs agreement with software vendor VMware.
12:17 Analyse GSK: drug reduces exacerbations in COPD.
12:14 Analyse Diageo: still positive, Credit Suisse raises target price.
11:46 Analyse SES: agreement extended with Sky News International.
11:31 Analyse Credit Suisse: Société Générale upgrades to buy.
11:23 Analyse TomTom: to power Sony prototype device for biking.
11:20 Analyse KBC: wealth manager FMR owns 3.01%.
11:12 Analyse BP: files registration for IPO of US pipeline assets.
10:53 Analyse Peugeot SA: SG does not believe in a 'dieselgate'.
10:28 Analyse ING Group: supervisory board member to step down.
10:17 Analyse Faurecia: Bryan Garnier raises target price.
10:09 Analyse Capgemini: confirms its targets from London.
09:55 Analyse Fraport: passengers at Frankfurt airport up 5% in August.
09:51 Analyse Novartis: Sandoz applies for blood cancer drug biosimilar.
09:45 Analyse Crédit Agricole: sells 16.2% of BSF'S capital.
09:35 Analyse Thales: finalises acquisition of Guavus.
09:23 Analyse Solvay: will produce PEKK in the US.
09:16 Analyse EDF: end of allocation contract with Swiss nuclear power.
09:08 Analyse Dassault Systèmes: wins contract with Valmet.
09:01 Analyse Vivendi: makes successful bond issue.
16:23 Analyse Société Générale: sells 49% of Fortune SG.
15:11 Analyse Facebook: fined in Spain.
15:06 Analyse SGS: Credit Suisse upgrades rating.
14:52 Analyse Vodafone: Jefferies raises target price - cites yield.
14:50 Analyse BP: to combine Argentina subsidiary with Bridas unit.
14:45 Analyse Peugeot: Invest Securities cuts target price.
12:38 Analyse Time Warner: 'It' breaks September box-office record.
12:25 Analyse GSK: phase III study shows inhaler improves asthma control.
12:23 Analyse Sky: Liberum raises estimates, maintains 'hold' rating.
12:13 Analyse Merck KGaA: strategic collaboration in oncology big data.
12:10 Analyse Engie: wins contract in the UK.
12:03 Analyse Boeing: builds 7 satellites for operator SES.
12:00 Analyse KBC: sells Polish unit to PKO Bank Polski.
11:40 Analyse Airbus: prepares the Govsatcom program.
11:25 Analyse Sainsbury: Jo Harlow named as non-executive director.
11:18 Analyse Vodafone: major investment in Germany.
11:05 Analyse H&M: shares jump after Credit Suisse upgrade.
10:57 Analyse Altice: wins broadcasting rights for basketball matches.
10:49 Analyse Saint-Gobain: equips a cross-border tramway.
10:38 Analyse Faurecia: Oddo BHF raises its earnings estimates.
10:29 Analyse Nokia: defines a strategy for 5G.
10:23 Analyse E.On: Bryan Garnier raises its target.
10:21 Analyse AstraZeneca: shares rise after positive clinical results.
10:14 Analyse Novartis: positive results in melanoma and ophthalmology.
10:10 Analyse EDF: electrical equipment transported to the Antilles.
09:47 Analyse Roche: two drugs fail in late-stage trials.
09:32 Analyse SFR: deputy CEO to leave.
09:22 Analyse Ipsen: EMA validates an application for cabometyx.
08:58 Analyse Valeo: renews takeover bid on FTE.
08:55 Analyse Sanofi: first results from study on dupilumab.
16:24 Analyse Nvidia: Canaccord Genuity raises estimates further.
15:33 Analyse Verifone: disappointing outlook.
14:52 Analyse Peugeot: denies fraudulent strategy.
14:31 Analyse Kraft Heinz: 29-year old financier David Knopf named CFO.
14:22 Analyse Johnson & Johnson: Janssen prostate drug shows improvements.
14:03 Analyse Bristol-Myers: acquisition of IFM Therapeutics complete.
14:01 Analyse Eli Lilly: positive results for galcanezumab.
12:44 Analyse GlaxoSmithKline: exercices option with T-cell tumour therapy
12:28 Analyse Diageo: kicks off share buyback program.
12:19 Analyse Publicis: Blackrock stake above 5% of capital.
12:12 Analyse Swatch Group: RBC Capital Markets ups target price.
12:07 Analyse WPP: Liberum cuts target price; maintains 'buy'.
12:00 Analyse Valeo: UBS still strongly believes in stock.
11:48 Analyse AXA: Deutsche Bank upgrades to buy.
11:30 Analyse STMicroelectronics: will enter CAC 40 on 18 September.
11:16 Analyse Burberry: Credit Suisse plays group's revival.
11:09 Analyse AkzoNobel: tough environment prompts cut in 2017 guidance.
10:42 Analyse Colas: acquires stake in quarries in southwest France.
10:29 Analyse Roche: progress made with cancer immunotherapies.
10:28 Analyse Novartis: Amgen migraine drug reduces symptoms.
10:21 Analyse EDF: Bryan Garnier still 'neutral', but raises target price.
09:55 Analyse AkzoNobel: CFO steps down for health reasons.
09:49 Analyse Ahold Delhaize: COO for Europe to retire next year.
09:46 Analyse L'Oréal: finalises disposal of The Body Shop.
09:41 Analyse Sanofi: cemiplimab designated 'breakthrough therapy' by FDA.
09:30 Analyse Bourbon: changes in top management.
09:26 Analyse Fnac Darty: entry into SBF 120 index.
09:06 Analyse Air France-KLM: passenger traffic up 3.3% in August.
09:00 Analyse Dassault Aviation: the Rafale selected by Belgian defense.
08:55 Analyse Rubis: very solid H1 results.
08:52 Analyse Natixis: acquires 40 % of BPCE Assurances.
16:44 Analyse WH Smith: RBC Capital Markets raises target price.
16:44 Analyse BMW: big offensive in electric vehicles.
16:08 Analyse Statoil: adds two exploration licenses in South Africa.
15:35 Analyse Dassault Systèmes: contract with Rimac Automobili.
15:22 Analyse Engie: in exclusive talks for takeover of MCI.
15:00 Analyse Sanofi: Alnylam suspends fitusiran studies.
14:46 Analyse Airbus: will modernise A380 cabins for Qantas.
14:31 Analyse Nestlé: buys US plant-based food maker Sweet Earth.
14:25 Analyse Amazon: to open second headquarters in North America.
14:22 Analyse General Mills: maintains annual targets.
12:39 Analyse Accenture: acquires two firms in the US.
12:35 Analyse Wendel: NAV around 166 euros per share.
12:31 Analyse Deere: buys machine learning firm Blue River Technology.
12:19 Analyse Airbus: Ana receives its first A321neo.
12:16 Analyse Unilever: buys UK-based herbal tea maker Pukka.
12:13 Analyse Innogy: whets Iberdrola appetite.
12:10 Analyse Bayer: submits hemophilia A drug for European approval.
12:03 Analyse Volkswagen: Audi sales up sharply in August.
11:48 Analyse Dixons Carphone: shares drop after RBC downgrade.
11:45 Analyse Carrefour: UBS says stop selling.
11:25 Analyse Barry Callebaut: reinforces presence in North America.
11:03 Analyse HeidelbergCement: shares lifted by broker upgrade.
10:50 Analyse Logitech: new home security cameras for Apple users.
10:45 Analyse AstraZeneca: asthma drug shows positive results in trial.
10:35 Analyse Wendel: Société Générale still a buyer.
10:06 Analyse Nokia: private wireless network extended as 5G nears.
09:54 Analyse SAP: chosen by German automotive supplier ZF.
09:51 Analyse Bourbon: net loss rises in H1.
09:08 Analyse Wendel: departure of board chairman at the end of December.
09:02 Analyse Altran: H1 EBIT margin improves.
08:56 Analyse Sanofi: rated AA at European agency Scope.
08:47 Analyse Ingenico: bond issue largely oversubscribed to.
08:43 Analyse Air Liquide: wins long-term contract in Mexico.
15:44 Analyse trivago: shares fall below IPO price after warning.
15:38 Analyse Amazon: first fulfillment center to open in New York.
15:25 Analyse Kone: Jefferies initiates coverage with 'buy' rating.
14:50 Analyse Airbus: United Airlines increases A350 XWB order to 45.
14:45 Analyse Shell: to invest 1 billion dollars in Mexico.
14:40 Analyse Merck: to acquire Germany's Rigontec for 115 million euros.
14:30 Analyse HP Enterprise: beats consensus in Q3.
12:43 Analyse Vivendi: towards the end of the Mediaset crisis?
12:29 Analyse Dassault Systèmes: Invest Securities no longer a buyer.
12:17 Analyse Sports Direct: shares up after optimistic trading update.
12:10 Analyse Luxottica: Bryan Garnier adjusts target price.
12:01 Analyse Kone: wins order for 112 elevators and escalators in China.
11:51 Analyse Nokia: further steps into 5G with new 4G features.
11:47 Analyse Vodafone: sells Vodacom stake for 960 million euros.
11:42 Analyse Bouygues: Credit Suisse still a buyer.
11:20 Analyse Daimler: Mercedes-Benz signs partnership with Tidal.
11:14 Analyse Essilor: Bryan Garnier adjusts target price.
11:09 Analyse Dong Energy: Credit Suisse removes shares from Focus List.
10:46 Analyse ABB: unveils collaborations with Amazon and Sonos for home.
10:42 Analyse Almirall: shares jump over 4% after broker upgrade.
10:37 Analyse Kering: launches a charter for models.
10:27 Analyse easyJet: passenger traffic up sharply in August.
10:22 Analyse Thales: new tramway contract in Taiwan.
10:00 Analyse Novo Nordisk: to pay 59 million dollars to settle US probe.
10:00 Analyse Schneider: Société Générale still a buyer after Aveva.
09:56 Analyse E.ON: starts building power storage facility in West Texas.
09:52 Analyse Roche: anti-cancer drug shows benefit in study.
09:46 Analyse Engie: wants to buy shares sold by French State.
09:19 Analyse Altamir: optimistic about year.
09:04 Analyse Rexel: stock jumps with analyst confirming rating.
09:02 Analyse Scor: confident in its 'Vision in Action' targets.
09:02 Analyse Valeo: makes 600 million euro bond placement.
09:01 Analyse Eurotunnel: best summer ever.
17:00 Analyse Thales: to modernise Norway's air navigation systems.
16:30 Analyse GSK: to focus on COPD data at upcoming congress.
16:19 Analyse DowDuPont: Jefferies raises target price.
16:16 Analyse STMicroelectronics: Mediatek interates NFC technology.
15:56 Analyse Siemens: to repower two wind farms in Texas.
15:49 Analyse Oracle: Credit Suisse initiates with 'outperform' rating.
15:08 Analyse Veolia: Oddo BHF maintains its rating.
14:43 Analyse Enel: RBC downgrades 'outperform rating'.
14:34 Analyse LVMH: a new head of Moët Hennessy.
14:27 Analyse Qualcomm: Seoul High Court denies appeal in KFTC case.
14:20 Analyse Alstom: inauguration of a metro in India.
14:07 Analyse Essilor: New Zealand approves merger with Luxottica.
12:21 Analyse United Technologies: buys Rockwell Collins as expected.
12:13 Analyse Orpea: Oddo still a buyer.
12:03 Analyse H&M: shares weaker after broker cuts target price.
11:50 Analyse Anglo American: De Beers' diamond sales down.
11:40 Analyse Carrefour: Credit Suisse downgrades rating.
11:30 Analyse Rexel: market is too pessimistic, says UBS.
11:20 Analyse Enel: RBC downgrades to 'sector perform'.
11:02 Analyse Henkel: Société Générale still a buyer.
10:45 Analyse Ryanair: August passengers up 10%.
10:28 Analyse Inditex: Bryan Garnier still a buyer, despite the dollar.
10:15 Analyse Merck KGaA: exploring 'options' for consumer health business
10:10 Analyse Novartis: positive results for pediatric multiple sclerosis.
10:05 Analyse Schneider Electric: complicated merger with Aveva.
09:50 Analyse Aveva: stock soars after agreement with Schneider Electric.
09:44 Analyse Euronext: cash volumes up almost 25% in August.
09:31 Analyse Carmila: 9.4% rise in EPRA NAV per share.
09:23 Analyse BPCE: new organisation of procurement division.
09:11 Analyse SFR: Altice files public repurchase offer.
16:54 Analyse Boeing: positive decision from WTO.
16:44 Analyse Air Berlin: EU approves rescue aid of 150 million euros.
16:38 Analyse Daimler: to enter shared rides market with US start-up.
15:54 Analyse Orange: signature of lease with Altarea Cogedim.
15:23 Analyse Inditex: shares lose ground on broker's comment.
14:51 Analyse Renault: presents a concept-car in Frankfurt.
14:23 Analyse Randstad: stock up with an analyst's upgrade.
13:52 Analyse Air France-KLM: shareholders support strategy.
12:21 Analyse Deutsche Bank: Credit Suisse upgrades from underperform.
12:08 Analyse Adidas: finalises a disposal.
12:01 Analyse Ubisoft: Guillemot family group stake above 15%.
11:59 Analyse AkzoNobel: completes the acquisition of France's Disatech.
11:33 Analyse Ferrari: Scuderia renews partnership with Marlboro's owner.
11:17 Analyse Valeo: Blackrock stake falls below 5% of VR.
11:15 Analyse Ageas: Norges Bank raises stake to 3.06%.
10:56 Analyse Sodexo: Oddo BHF upgrades rating; raises target price.
10:38 Analyse ABN Amro: Nordea's Bornfeld named as chief of technology.
10:25 Analyse Gemalto: Invest Securities cuts target price.
10:06 Analyse Coface: Sino Guarantee interested.
09:59 Analyse FCA: shares slightly up after S&P upgrade.
09:50 Analyse Novartis: CEO to step down, chief medical officer to succeed
09:25 Analyse Bureau Veritas: private placement in the US.
09:18 Analyse Total: sells remaining stake in Gina Krog.
09:07 Analyse Scor: agency A.M. Best upgrades ratings.
09:05 Analyse M6: acquires French radio stations from RTL group.
09:04 Analyse Bolloré: H1 net income, group share of 333 million euros.
16:39 Analyse Peugeot: new director of financial communication.
16:29 Analyse GM: US sales up 7.5% in August.
16:26 Analyse Zurich Insurance: appoints new chief risk officer.
16:23 Analyse Ford: US sales down 2.1% in August.
15:29 Analyse Gemalto: 'our view of share is unchanged' Oddo says.
14:57 Analyse Peugeot: strongest growth amongst French brands.
14:40 Analyse BT group: will leave Eurostoxx 50 index on 18 September.
14:38 Analyse Wolters Kluwer: acquires Belgian tax software firm.
14:31 Analyse Glencore: buys Peruvian mine from Nyrstar.
14:28 Analyse Peugeot: new headquarters in Poissy.
14:12 Analyse DuPont: merger with Dow is now complete.
13:50 Analyse Constellium: up 6%, due to takeover rumour.
12:09 Analyse Nyrstar: sale of a mine in Peru finalised.
11:56 Analyse Safran: selected for USMC Sniper Range Finder.
11:49 Analyse RTL Group: Credit Suisse cuts target price.
11:30 Analyse Pernod Ricard: preferred stock, according to SG.
11:08 Analyse Vivendi: Oddo BHF remains a buyer after results.
10:45 Analyse ITV: shares slightly up after UBS upgrades to 'neutral'.
10:39 Analyse Inditex: RBC cuts target price due to strong euro.
10:35 Analyse Elis: meetings validate planned merger with Berendsen.
10:15 Analyse Pernod-Ricard: Bryan Garnier still a buyer; adjusts target.
10:12 Analyse Zurich Insurance: Commerzbank maintains 'reduce' rating.
10:06 Analyse Arkema: enquiry into Crosby accident in the US.
09:37 Analyse Airbus: to take BT group's place in Eurostoxx 50 index.
08:58 Analyse Gemalto: sharp fall in H1 income.
08:55 Analyse Vivendi: confirms FY 2017 targets.
08:53 Analyse Sopra Steria: plans to acquire Galitt.
08:51 Analyse Iliad: interim earnings up 22%.
16:15 Analyse Umicore: reasons to be cheerful, Liberum says.
16:02 Analyse Bayer: submits hemophilia treatment for FDA approval.
15:46 Analyse Roche: to present oncology portfolio at 2017 ESMO Congress.
14:50 Analyse Costco: August same-store sales up 7.3%.
14:45 Analyse Campbell: fourth-quarter sales drop 1 percent.
14:37 Analyse Dollar General: increases target EPS range.
14:28 Analyse Steinhoff: sales boosted by acquisitions.
14:12 Analyse Eiffage: Bryan Garnier downgrades stock.
12:21 Analyse TomTom: launches new fitness products.
12:02 Analyse BBVA: Chilean subsidiary for sale; Scotiabank a candidate.
11:52 Analyse AstraZeneca: over 40 presentations at upcoming ESMO.
11:34 Analyse BNP Paribas: Saur denies it is up for sale.
11:29 Analyse Novartis: Bryan Garnier raises target after CAR-T success.
11:18 Analyse Eiffage: Oddo BHF raises its estimates and target price.
11:10 Analyse G4S: shares fall after UBS downgrade.
11:05 Analyse Salvatore Ferragamo: Bryan Garnier no longer a seller.
11:00 Analyse BHP: RBC downgrades to 'underperform'
10:50 Analyse Colas: interim loss deepens; management cautious.
10:27 Analyse LVMH: Bryan Garnier no longer a buyer.
10:14 Analyse Givaudan: shares rise for second day after investor meeting.
09:55 Analyse Carmila: Société Générale begins coverage with buy rating.
09:36 Analyse Roche: FDA approves treatment for CAR T-linked syndrome.
09:32 Analyse Carrefour: Jefferies downgrades buy rating.
09:27 Analyse Novartis: FDA approves CAR-T therapy for pediatric use.
09:20 Analyse Chargeurs: acquisition in Lombardy.
09:10 Analyse Pernod-Ricard: FY earnings up 13%.
09:07 Analyse Sopra Steria: finalises acquisition of Kentor.
09:03 Analyse Bouygues: returns to profit in H1.
08:59 Analyse Carrefour: targets 2% to 4% sales growth in 2017.
08:58 Analyse Eiffage: targets positive FY sales growth.
16:23 Analyse Munich Re: shares up after broker upgrade.
16:17 Analyse Merck: Credit Suisse cuts estimates after clinical trial.
15:52 Analyse Eli Lilly: to resubmit filing for rheumatoid arthritis drug.
15:24 Analyse Ubisoft: Guillemot family group exceeds 20% stake.
15:01 Analyse Amazon: collaborates with Microsoft in digital assistants.
14:52 Analyse Telefonica: agrees capital increase for Colombia's ColTel.
12:50 Analyse Logitech: launches two new gaming products.
12:21 Analyse Rio Tinto: opens new iron ore mine in Western Australia.
12:17 Analyse Acerinox: UBS upgrades to buy.
12:05 Analyse Airbus: Sentinel-5 Precursor joins its launch site.
12:05 Analyse K+S: Credit Suisse maintains 'underperform' rating.
11:42 Analyse Arkema: 'serious' situation at Crosby plant in Texas.
11:27 Analyse Faurecia: towards potentially big acquisition in the autumn.
11:01 Analyse Renault: to present new Duster at Frankfurt show.
10:53 Analyse Uniper: UBS returns to 'neutral' rating.
10:49 Analyse AB Inbev: Bryan Garnier's best brewer alongside Heineken.
10:38 Analyse SKF: Liberum removes stock from conviction list.
10:22 Analyse TF1: offers good entry point, according to Bryan Garnier.
09:58 Analyse Genmab: Seattle Genetics exercises option on cancer drug.
09:44 Analyse Eurofins Scientific: H1 earnings up 22.4%.
09:26 Analyse Vivendi: at last files takeover bid on Havas.
09:04 Analyse Total: starts production at Edradour & Glenlivet field.
08:57 Analyse bioMérieux: raises annual targets.
08:51 Analyse Thales: 787-9 commissioned with AVANT system.
16:34 Analyse Bayer: enrolls first US patient in phase III trials.
16:32 Analyse Nike: shares fall; Morgan Stanley cuts target.
16:11 Analyse Bristol-Myers: positive data for anticoagulant Eliquis.
16:02 Analyse Amazon: new horror series 'Lore' to begin in October.
15:51 Analyse ExxonMobil: Jefferies cuts target price.
15:45 Analyse CGG: collapses after a negative analysis.
14:39 Analyse McDonald's: big IT contract with Capgemini.
14:28 Analyse Pfizer: FDA grants priority review to leukemia drug.
14:16 Analyse Best Buy: beats consensus in Q2.
12:23 Analyse opens new fulfillment center in Oregon.
12:13 Analyse Merck: Anacetrapib misses statistical significance in study.
11:59 Analyse Linde: new request for FTC precision.
11:57 Analyse Statoil: only limited gas found in Barents Sea project.
11:48 Analyse Pernod Ricard: Oddo BHF remains neutral before results.
11:38 Analyse Cnova: best summer sales for Cdiscount.
11:21 Analyse AstraZeneca: agreement with Takeda for Parkinson's disease.
11:08 Analyse Wendel: Société Générale upgrades to buy.
11:06 Analyse Heineken: acquisition of Punch Taverns pubs now complete.
10:57 Analyse ProSiebenSat.1: shares slump after warning.
10:41 Analyse Elior: Bryan Garnier downgrades rating.
10:24 Analyse Altice: Credit Suisse maintains neutral rating.
10:15 Analyse Philips: launches new voice recorder app.
10:06 Analyse SAP: to start digital collaboration project for BASF.
09:55 Analyse Eiffage: contract for water production in Djibouti.
09:53 Analyse Almirall: appoints ex-Sanofi executive as new CEO.
09:41 Analyse Renault: joint venture for electric vehicle in China.
09:33 Analyse CGG: starts a multi-client study in Brazil.
09:17 Analyse Vinci: construction contract in Hô Chi Minh City.
09:06 Analyse JCDecaux: finalises acquisition of LC Outdoor.
09:05 Analyse Capgemini: multi-year contract with Mc Donald's.
16:23 Analyse Merck KGaA: acquisition of Canada's Natrix.
16:05 Analyse Lagardère: Anne Sinclair will be a columnist at JDD.
15:20 Analyse E.ON: former CEO dies.
14:38 Analyse Bristol-Myers: Eliquis reduces stroke risk.
14:29 Analyse Estée Lauder: could be taken over.
12:24 Analyse Ferrari: Scuderia extends Sebastian Vettel deal.
12:20 Analyse Ageas: Norges Bank owns 3.12% of voting rights.
12:06 Analyse Philips: collaboration agreement with US-based HeartFlow.
11:44 Analyse AstraZeneca: FDA approves expanded use for Faslodex.
11:42 Analyse SES: change for two satellite launches.
11:29 Analyse Exxonmobil: acquisition of a site in Singapore finalised.
11:18 Analyse Havas: Oddo BHF downgrades to neutral.
11:10 Analyse Novartis: ACZ885 reduces cardiovascular risk.
11:02 Analyse Bayer: Xarelto shows heart benefit in large study.
11:01 Analyse Havas: Invest Securities say investors should tender shares.
10:47 Analyse Novo Nordisk: FDA approves new indication for Victoza.
10:31 Analyse Michelin: Oddo BHF upgrades to buy.
10:11 Analyse Peugeot: launches campaign for the new 308.
09:58 Analyse Altice: starts 1 billion euro share buyback program.
09:58 Analyse STMicro: Bryan Garnier maintains buy rating.
09:46 Analyse Roche: FDA grants priority review to lymphoma drug.
09:15 Analyse Sanofi: completes acquisition of Protein Science.
09:03 Analyse Havas: abandons annual growth target.
 1   2   3   4   5   6  ... >